Item 6.1 Nov 09 Finance and Workforce Report
description
Transcript of Item 6.1 Nov 09 Finance and Workforce Report
1p1 November 09
Title slide
NOVEMBER 2009NOVEMBER 2009
Linda Potter, Director of FinanceLinda Potter, Director of Finance
FINANCE & WORKFORCE REPORTFINANCE & WORKFORCE REPORT
2p2 November 09
• Executive Summary
• Financial Risk Rating
• Income and Expenditure (Trust)
• Performance Summaries
• CIP Summary
• Service Line Report (October 09 summary)
• Balance Sheet
• Cash Flow
• Capital Report
CONTENTS
3p3 November 09
EXECUTIVE SUMMARYFINANCIAL PERFORMANCE REPORT
EIGHT MONTHS TO END NOVEMBER 2009
FINANCIAL PERFORMANCE SUMMARY
All monetary figures stated in £ millions
CurrentActual 4.7
Financial Budget 4.5
PositionVariance Favourable
/ (Adverse) 0.2
EBITDA £ 9.4 Operational surplus is above budget by1.4% due to the better than budget income position.
% 9.5% YTD Target: 9.6%
CIP Target 2.7(savings)
Actual 3.4
I&E Forecast Outturn Recurrent 6.0 Current projected forecast outturn based on November financial position (November contract income estimated).
Retained 6.0 No significant non-recurrent financial activities are expected.
Capital Plan FY 5.3 The annual capital plan forecasts capital expenditure increasing during the remainder of the financial year.
Actual Ytd 2.3 Expenditure on clinical equipment, maintenance and IM&T; further capital spend phased for the remainder of the year.
CashCurrent Balance 11.0
F'cast y/e Balance 11.5 Current lower creditor balance expected to be achieved by year-end, capital expenditure re-profiled.
Working Capital/ LiquidityDebtors 5.2
Creditors 15.4 Small decrease on October (£15.9m); creditor value will vary linked to timing of creditor payment runs and accrual levels
Liquidity 40 days
Overall Financial Risk RatingFRR score 5
Key Budget Highlights
Risks & Opportunities
Savings targets are proactively monitored through Directorate Performance Reviews and as part of Transformation programme to ensure CIP targets are met.
Reforecasting exercise for activity and contract income has been completed and is subject to agreement with NHS Suffolk before being included in future forecast.
Ahead of planned savings driven by higher than planned achievement in pay savings both recurrent and non-recurrent. Surgery underperformance on CIPs linked to extra sessional payments and costs of completing work by external bodies.
Surplus. The cumulative financial position reflects an adjustment for NCA income made in November, resulting in the Trust effectively breaking even in the month. Contract income for November has been estimated pending the publication of November priced activity. Income is 2.6% above budget, operational costs are 2.8% over budget.
Budget surplus.
Income above both plan and current forecast have improved the performance against budget. Pay costs and clinical supplies costs continue to exceed budget reflecting both recruitment difficulties and activity above plan levels. Total pay costs are £64.1m (1.3% over budget) and include £1.68m of agency costs. (£1.56m Oct)
Improved position October balance (£6.1m). Timing of invoicing and cash receipts will affect balances month to month
Creditors continue to be paid promptly - 10 day payment performance is 65%; current low spend on capital contributing to high cash balance.
High variable costs of activity (sessional payments, o/time, etc) and continued agency costs are driving pay costs above budget, though income is also above plan offsetting the impact of these higher costs. Recruitment plans being actively managed to minimise agency costs.
Improved cash and debtor position has increased the Trusts ability to cover immediate liabilities.
Peformance monitoring will be key to maintaining income and minimising contract penalties, regular SLA reviews are held with Suffolk PCT.
Strong performance in all rating measures for the 8 months to November. The forecast outturn rating remains at 4.
The November postion reflects continued agency cost and clinical consumables cost pressures, and additional expenditure on replacement MSE. Income reflects an adjustment for NCA income for the first six months of the year which had been overstated.
The high-cost drugs budgets now include adjustments for over-performance.
4p4 November 09
FINANCIAL RISK RATING (FRR – SHA model)
To move the Underlying Performance rating for full year outturn forecast from amber to green (from 3 to 4) the Trust would need to reduce operational costs or increase income by approximately £450k. This would have the effect of increasing the forecast outturn surplus from £6.0m to £6.4m.
Financial Risk Ratings Month Nov-09
Criteria Metric Weight 5 4 3 2 1
Annual Plan rating
09/10Score09/10
Risk ratings09/10
Score09/10
Risk ratings09/10
Underlying performance EBITDA margin % 25% 11 9 5 1 <1
3 9.5% 4 8.7% 3
Achievement of plan EBITDA achieved % 10% 100 85 # 70 50 <50
5 155.1% 5 123.2% 5
Financial efficiency Return on assets % 20% 6 5 3 2 <-2
5 11.8% 5 11.8% 5
I&E surplus margin % 20% 3 2 1 -2 <-25 4.8% 5 4.0% 5
Liquidity Liquid ratio days 25% 60 25 15 10 <105 39.9 4 39.9 4
Average4.50 4.50 4.25
Overriding rules Overriding rules
0 0 0
Overall rating Overall rating5 5 4
At least one criteria on Plan 1 or 2
Actual YTD Full year outturn
forecast
5p5 November 09
£000's Full Year Actual Budget Variance
Previous Month
Variance Full Year
Contract Income 133,370 89,014 87,904 1,110 1,524 133,503Other Patient related income 2,140 2,076 1,427 648 440 2,781
Income From Patient Activities 135,510 91,090 89,332 1,758 1,964 136,284
Other Operating Income 11,314 8,355 7,588 768 664 12,374
TOTAL INCOME 146,824 99,445 96,919 2,526 2,628 148,658
Pay expenses 95,248 64,076 63,256 (820) (586) 97,190Drugs 10,392 7,287 7,258 (29) 13 10,812
Supplies 11,360 8,046 7,562 (484) (313) 12,301Other Expenses 17,594 10,593 9,491 (1,103) (1,193) 15,381
TOTAL OPERATING EXPENSES 134,593 90,003 87,567 (2,435) (2,079) 135,684
EBITDA 12,230 9,442 9,352 91 549 12,974EBITDA margin 8.3% 9.5% 9.6% -0.2% 8.7%
Depreciation 4,237 2,674 2,825 151 126 3,986Finance Costs (PDC Dividend & Interest) 2,993 2,007 1,995 (12) (13) 2,986
Gain/(Loss) on Disposal 0 (2) 0 (2) (2) (2)
SURPLUS/(DEFICIT) 5,000 4,760 4,532 228 660 6,000
INCOME AND EXPENDITURE ACCOUNT EIGHT MONTHS TO END NOVEMBER 2009
YEAR TO DATEBUDGET FORECAST
COMMENTS ON YEAR-TO-DATE VARIANCES:▪Contract income for November has been estimated.The SLA income budget has been phased on the basis of last year actual profile. October actual income was £0.16m below estimate forecast and an adjustment for NCA income has led to to lower cumulative variance on contract income. The final agreement with Suffolk PCT on Qtr 1 contract position is still outstanding and carries a potential risk of £100k. ▪ Pay costs overall are 1.3% above budget. Agency and locum costs continue to be incurred to cover vacancies, absence and activity demands both in medical and non-medical staff groups. • The movement on the supplies variance is due to further purchases of new minor clinical equipment during November. ▪ The adverse variance on Other Expenses includes central costs for consultancy and expenditure on ward furnture and equipment. • The forecast outturn includes the assumption that approx. £0.3m costs will be funded from reserves over the remaining months of the year.
6p6 November 09
• The following schedules show the financial and workforce performance for the whole Trust and each of the directorates.• Activity relates to the period to October 09 and variances are based on an estimated profile.• Contract income for November has been estimated.• The Trust currently forecasts to achieve a surplus of £6m.
Green Variance at >0%Amber Variance at 0% >< -2%Red Variance at > -2%
•The Trust has generated a surplus of £4.8 m, £0.2m above the revised, phased budget. Pay costs remain at just over 1% above budget, and include £1.68m of agency costs. Non-pay costs are generally on or below budget, which includes costs for new clinical and medical equipment purchased across the Trust. •Overall nursing staff costs are 1.5% below budget. Medical staff costs (incl. agency) are 5.6% over budget.•The Trust currently employs 2214.6 WTE staff an increase of 14 wte since October.•There are currently 72.23 WTE (91 headcount) employees on maternity leave, compared to 48.08 WTE (60 headcount) for the same period last year. There are several areas of the hospital where the high level of maternity leave could impact on service delivery and are therefore back filled through temporary staffing.• Sickness rate for the month is 4.15%. The cumulative sickness rate for the year is 3.78%
PERFORMANCE SUMMARIES
TRUST
TRUST
November 2009 £000 Current Variance to
BudgetVariance
%
Last month
Variance %
Same period
Last year variance
%
Oct 2009 £000Actual to date Variance %
Last month
Variance %
Same period Last
year variance %
November 2009 £000Actual to date
Last month
Same period
Last yearIncome 2,526 2.6% 3.1% -13.8% SLA Activity (No.) 1,466,884 3.3% 2.9% 31% Employed WTE 2214.6 2199.1 2220.2
Pay (820) -1.3% -1.1% -2.2% Sickness Rates (Oct only) 4.2% 3.8% 3.9%Non-Pay (1,477) -5.1% -5.5% -53.9% SLA Income (£000) 75,414 4.7% 5.7% 5% Mat Leave 3.2% 3.3% 1.9%Net Total 228 5.0% 15.9% 2.0% Vacancy level (wte) 199.38 212.71 175.85
Temp Staff % of Total Pay 7.6% 7.5% 6.4%CIPs 714 26.1% 25.9% 15.6% Agency Staff (£000's) 1,681 1,557 1,310
NHS Locum/Bank Staff (£000's) 3,184 2,643 2,632
FULL YEAR 2009/10 £000Forecast outturn Budget Variance
Variance %
FULL YEAR 2009/10 £000Forecast outturn Budget Variance
Variance %
Net Total (Surplus)/Deficit (6,000) (5,000) 1,000 20.0% SLA Activity (No.) 2,470,115 2,400,134 69,981 2.9%
CIPs 4,676 3,982 694 17.4% SLA Income (£000) 134,102 132,000 2,102 1.6%
Financial Performance Contract Performance Workforce Performance
7p7 November 09
MEDICINE DIRECTORATE
• Month 7 (October) activity showed a Directorate over performance in the region of 5,400 actual activity, and £900k in value. November activity not available at the time of writing this report.• The Directorate was over spent £94k in the month.• Income was £39k better than budget - the majority of this was due to recovery of consultant staff costs (£16k - Oncology and Neurology), Nurses (£7k), R & D income (5k), alcohol awareness (£4k) and £6k funding for equipment for the Stroke service - much of this income is matched by additional cost.• Covering consultant vacancies in Accident & Emergency and Cardiology added significantly to costs: A&E £40k in the month, Cardiology incurred £35k in additional sessions and a further £5k of locum costs. Other than Cardiology, additional sessional costs were less than previous months. Further locum costs were incurred to cover consultant maternity leave in Haematology.• Nursing costs were £41k above budget. Agency costs reduced to £3k in the month, bank costs remained high. £15k referred to posts funded by income detailed above, £19k for posts that have been approved, via business cases, with no additional funding (Medical Day Treatment Unit and Discharge Unit). The remainder was concentrated on a number of wards with high levels of maternity leave and/or sickness in order to maintain clinical standards.• Non pay costs were underspent, including a reduction in charges for Mobile Angiography - contract based on number of patients seen.
MEDICINE
November 2009 £000 Current Variance to
BudgetVariance
%
Last month
Variance %
Same period
Last year variance
%
Oct 2009 £000Actual to date Variance %
Last month
Variance %
Same period Last
year variance %
November 2009 £000Actual to date
Last month
Same period
Last yearIncome 237 12.1% 11.5% -37.3% SLA Activity (No.) 81,701 7.1% 8.3% 8% Employed WTE 662.2 659.4 628.5
Pay (754) -4.1% -3.8% -4.2% Sickness Rates (Oct only) 5.1% 4.7% 4.2%Non-Pay (128) -2.0% -2.4% -5.6% SLA Income (£000) 24,214 4.0% 7.2% 5% Mat Leave 2.5% 2.7% 2.6%Net Total (645) -2.8% -2.8% -3.5% Vacancy level (wte) 45.11 48.09 54.23
Temp Staff % of Total Pay 9.8% 9.9% 9.8%CIPs 281 37% 33.5% -10.8% Agency Staff (£000's) 705 662 718
NHS Locum/Bank Staff (£000's) 1,155 972 976
FULL YEAR 2009/10 £000Forecast outturn Budget Variance
Variance %
FULL YEAR 2009/10 £000Forecast outturn Budget Variance
Variance %
Net Total Expenditure 35,399 33,840 (1,559) -4.6% SLA Activity (No.) tbc tbc #VALUE! #VALUE!
CIPs 1,547 1,116 431 38.6% SLA Income (£000) tbc tbc #VALUE! #VALUE!
Financial Performance Contract Performance Workforce Performance
8p8 November 09
There has been little change since last month’s report. Activity remains above plan by approx 12% along with the associated income. Outpatient demand continues to require additional sessions to manage demand in General Surgery, (particularly 2 week wait rapid access colo-rectal), T&O, ENT, Ophthalmology and Oral Surgery. The PCT are attempting to provide a GDP solution for minor oral surgery which, once implemented, will reduce demand in Oral (no time frame yet). New to follow up ratios are satisfactory. Discussions also taking place with Addenbrookes over additional permanent sessions for vascular and plastics.
Income for the month was better than budget due to invoices for the use of medical staff £104k, SLA Income £12k and Private Patients of £38k. Pay was more than budget primarily as a result of medical staff £514k, due to extra session payments, Prof. & Tech agency cost £109k, and nursing bank £278k but partially offset by £230k from staff vacancies. Non-Pay exceeds the budget £187k for contracted work – plastics, ENT, and dental. MSE was over by £276k due to equipment replacements and general supplies in theatres. Cost of appliances and other supplies were £96k over.
Sickness/absence and maternity leave rates have improved on the inpatients wards but the levels still necessitate backfill by bank staff.The use of agency staff was £271k for junior medical staff (Urology, T&O, ENT) and £104k for consultants (Anaesthetics). A further £109k for non-medical agency includes cover for Audiologist (£54k) and the Plaster Orderly (£55k) in the Fracture Clinic (this position has now been recruited to), plus £11k nursing. Locum cost were £355k, primarily in Anaesthetics for consultant cover and bank usage was £278k for nurses and £65k for medical secretaries to cover sickness, maternity leave and vacancies.
SURGERY DIRECTORATESURGERY
November 2009 £000 Current Variance to
BudgetVariance
%
Last month
Variance %
Same period
Last year variance
%
Oct 2009 £000Actual to date Variance %
Last month
Variance %
Same period Last
year variance %
November 2009 £000Actual to date
Last month
Same period
Last yearIncome 163 11.7% 13.5% -10.1% SLA Activity (No.) 80,974 11.6% 12.0% 14% Employed WTE 545.8 540.0 529.7
Pay (682) -3.9% -3.6% -6.4% Sickness Rates (Oct only) 4.1% 4.0% 4.4%Non-Pay (569) -10.2% -8.2% -13.6% SLA Income (£000) 29,152 15.3% 15.7% 2% Mat Leave 4.0% 3.9% 3.6%Net Total (1,087) -5.0% -4.2% -7.9% Vacancy level (wte) 55.4 61.3 35.2
Temp Staff % of Total Pay 6.5% 6.5% 4.7%CIPs (347) -53.3% -52.4% -46.7% Agency Staff (£000's) 496 473 227
NHS Locum/Bank Staff (£000's) 698 557 570
FULL YEAR 2009/10 £000Forecast outturn Budget Variance
Variance %
FULL YEAR 2009/10 £000Forecast outturn Budget Variance
Variance %
Net Total Expenditure 34,681 32,806 (1,874) -5.7% SLA Activity (No.) tbc tbc #VALUE! #VALUE!
CIPs 389 976 (587) -60.2% SLA Income (£000) tbc tbc #VALUE! #VALUE!
Workforce PerformanceContract PerformanceFinancial Performance
9p9 November 09
• The favourable variance to budget is driven mainly by £128.4k in vacant positions, £15.6k in lower drug cost, £13.2k lower rent costs for community midwifery clinic space, £22.2k in transport cost due to last year credits received, Lower SLA charges £0.9k, additional USAF income of £378.8k and £116.5k from EWTD funds. These savings were partially offset by extra session payments of £55.8k and £84.8k for the wards’ bank usage and £44.7k in MSE and other supply cost
• Activity data reflects a significant increase in gynaecology referrals over last year and recorded activity is 30.9% up year-on-year through October. Paediatric referrals are up 6.3% but recorded activity is down by 3.8% primarily due to no longer having the gastroenterology patients. Activity vs the SLA through October is down mainly in midwifery and obstetrics due to over-commissioned levels by the PCT. This will be now be subject to a contract variation.
• Sickness rates have improved from the October position but maternity leave has increased. Use of bank staff (£305.3k) reflects vacancy cover, maternity leave and long term sick cover. Paediatrics have used agency staff to support the service. Locum staff (£173.9k) are being used to cover the vacancies for the hybrid consultants in Paediatrics although part of this cost is offset by additional EWTD income (£116.5k). Non-NHS Agency cost is primarily due to Junior Doctor coverage in Paediatrics.
WOMAN & CHILD DIRECTORATEWOMAN & CHILD
November 2009 £000 Current Variance to
BudgetVariance
%
Last month
Variance %
Same period
Last year variance
%
Oct 2009 £000Actual to date Variance %
Last month
Variance %
Same period Last
year variance %
November 2009 £000Actual to date
Last month
Same period
Last yearIncome 494 80.1% 53.1% -107.7% SLA Activity (No.) 22,180 -13.9% -13.9% 22% Employed WTE 217.3 214.4 208.5
Pay (12) -0.2% 0.2% 1.3% Sickness Rates (Oct only) 2.2% 2.5% 4.3%Non-Pay 7 1.0% 6.6% -13.4% SLA Income (£000) 10,403 -19.6% -19.7% 10% Mat Leave 5.5% 4.4% 3.0%Net Total 489 7.1% 5.6% 5.4% Vacancy level (wte) 18.50 21.38 15.95
Temp Staff % of Total Pay 8.1% 7.7% 5.1%CIPs 129 59.3% 44.7% 123.0% Agency Staff (£000's) 72 65 37
NHS Locum/Bank Staff (£000's) 479 395 293
FULL YEAR 2009/10 £000Forecast outturn Budget Variance
Variance %
FULL YEAR 2009/10 £000Forecast outturn Budget Variance
Variance %
Net Total Expenditure 9,927 10,415 (488) 4.7% SLA Activity (No.) tbc tbc #VALUE! #VALUE!
CIPs 396 304 92 -30.3% SLA Income (£000) tbc tbc #VALUE! #VALUE!
Financial Performance Contract Performance Workforce Performance
10p10 November 09
CLINICAL SUPPORT DIRECTORATE
• The Directorate was over spent this month by £81k.• Income was greater than budgeted due to the continued support for the Early Intervention Team and running the Newmarket
hospital pharmacy service on an interim basis.• Radiology Consultants were successful in an appeal regarding on call duties and received an increase of one Programmed
Activity back dated to May 09. This is not included within budgets (net cost £25k year to date).• Consultant vacancies meant expenditure on locums in Chemistry (£4k) and Histopathology (£9k), with the latter also incurring
a further £11k in referred work. A locum Radiologist is working above their established hours to manage current departmental workload with additional sessions also being required.
• Vacancies in other professions are also being addressed, with Pharmacy now at establishment. There is still some agency staff to cover rehabilitation and Microbiology, which has several vacancies at the moment.
• Medical and Surgical equipment and Pathology equipment were above budget (£6k and £19k respectively), in part to cover activity levels, though there is some increase in analyser stocks with the new contract in chemistry about to start.
• The National Blood service contract was over spent by £19k this month, despite receiving a credit (national contingency savings) of £15k for the first six months, with more expected in January. Costs are being reviewed in light of the higher cost in the month.
CLINICAL SUPPORT
November 2009 £000 Current Variance to
BudgetVariance
%
Last month
Variance %
Same period
Last year variance
%
Oct 2009 £000Actual to date Variance %
Last month
Variance %
Same period Last
year variance %
November 2009 £000Actual to date
Last month
Same period
Last yearIncome 119 10.6% 11.2% -5.5% SLA Activity (No.) 1,280,357 3.0% 2.4% 35% Employed WTE 443.3 439.7 422.7
Pay 231 2.1% 2.8% 3.6% Sickness Rates (Oct only) 3.5% 3.0% 3.3%Non-Pay (202) -5.3% -4.4% -10.8% SLA Income (£000) 9,686 18.6% 16.6% 20% Mat Leave 4.0% 3.8% 2.1%Net Total 147 1.1% 1.9% 0.4% Vacancy level (wte) 31.02 34.28 37.78
Temp Staff % of Total Pay 6.4% 6.2% 6.0%CIPs 241 39.9% 49.4% 49.5% Agency Staff (£000's) 296 261 131
NHS Locum/Bank Staff (£000's) 387 315 465
FULL YEAR 2009/10 £000Forecast outturn Budget Variance
Variance %
FULL YEAR 2009/10 £000Forecast outturn Budget Variance
Variance %
Net Total Expenditure 20,370 20,452 82 0.4% SLA Activity (No.) tbc tbc #VALUE! #VALUE!
CIPs 1,141 876 265 30.3% SLA Income (£000) tbc tbc #VALUE! #VALUE!
Financial Performance Contract Performance Workforce Performance
11p11 November 09
IncomeContinues to improve.PaySSD – underspend as a result of vacancy.Estates – underspend as a result of vacancies.Facilities Admin – underspend due to vacancy.Non Pay underspend has reduced this month. Utilities continue to underspend due to lower tariffs.Central Med & Surg – overspend forecast on mattresses has been removed to central fund.WorkforceThe majority of short term sickness is within the Trust target of 3.5%. It was hoped that the Long Term sickness would reduce in October as some staff were on a phased return to work. Regular analysis of the sickness will highlight the variance.
FACILITIES DIRECTORATEFACILITIES
November 2009 £000 Current Variance to
BudgetVariance
%
Last month
Variance %
Same period
Last year variance
%
Oct 2009 £000Actual to date Variance %
Last month
Variance %
Same period Last
year variance %
November 2009 £000Actual to date
Last month
Same period
Last yearIncome 97 5.5% 4.2% -6.9% SLA Activity (No.) Employed WTE 264.3 264.9 259.64
Pay 84 1.8% 1.3% -3.5% Sickness Rates (Oct only) 5.0% 4.9% 3.8%Non-Pay 249 6.0% 8.8% -13.8% SLA Income (£000) Mat Leave 0.9% 0.2% 2.3%Net Total 430 6.0% 7.0% -8.4% Vacancy level (wte) 19.66 19.07 21.47
Temp Staff % of Total Pay 9.0% 9.1% 8.1%CIPs 233 94.8% 86.6% -12.6% Agency Staff (£000's) 28 23 104
NHS Locum/Bank Staff (£000's) 389 346 264
FULL YEAR 2009/10 £000Forecast outturn Budget Variance
Variance %
FULL YEAR 2009/10 £000Forecast outturn Budget Variance
Variance %
Net Total Expenditure 10,506 10,773 (267) 2.5% SLA Activity (No.)
CIPs 635 351 284 80.8% SLA Income (£000)
Financial Performance Contract Performance Workforce Performance
12p12 November 09
• Corporate report is a consolidation of Finance and Information, Human Resources and Communications, Medical Director, Nursing and Governance, Trust Office, Overhead, Sudbury and the Central Operations Directorates. Reserves are excluded from this report.
• The overall pay variance remains favourable. Agency and bank staff are still being used in Finance to support FT work, IT and payroll. The cost of bank nurses on mandatory training are included in these Corporate numbers.
• The Income variance is favourable due mainly to RTA (£204k variance) income and some funding which has associated unbudgeted costs, for example: Pandemic Flu, IT support contracts and Research.
• The Overheads budget includes a CIP for Collaborative Hub led savings, but these savings actually arise elsewhere throughout the Trust, contributing to the adverse variance. The non-pay variance also includes provisions for unbudgeted consultancy work associated with Transformation and Foundation Trust and other projects, creating the high adverse variance.
•The Maternity and sickness rates are below the overall Trust rate.
CORPORATE DIRECTORATECORPORATE
November 2009 £000 Current Variance to
BudgetVariance
%
Last month
Variance %
Same period
Last year variance
%
Oct 2009 £000Actual to date Variance %
Last month
Variance %
Same period Last
year variance %
November 2009 £000Actual to date
Last month
Same period
Last yearIncome 307 14.1% 14.7% -3.9% SLA Activity (No.) Employed WTE 173.7 172.7 171.2
Pay 313 6.3% 5.9% 3.5% Sickness Rates (Oct only) 3.3% 1.9% 0.6%Non-Pay (752) -21.0% -21.0% 44.8% SLA Income (£000) Mat Leave 0.5% 1.0% 0.3%Net Total (132) -1.2% -1.3% -0.6% Vacancy level (wte) 29.65 28.64 13.99
Temp Staff % of Total Pay 3.4% 3.2% 3.6%CIPs 178 67.1% 66.9% 48.1% Agency Staff (£000's) 84 73 93
NHS Locum/Bank Staff (£000's) 76 59 62
FULL YEAR 2009/10 £000Forecast outturn Budget Variance
Variance %
FULL YEAR 2009/10 £000Forecast outturn Budget Variance
Variance %
Net Total Expenditure 16,358 16,496 (138) 0.8% SLA Activity (No.)
CIPs 569 359 209 58.3% SLA Income (£000)
Financial Performance Contract Performance Workforce Performance
13p13 November 09
On the basis of the level of surgical activity delivered during the year the Performance Review Group has recognised that the original CIP target for Surgery will not be met, and despite Surgery seeking alternative CIPs, this will not be deliverable in year.
2009/10 CIP REPORT as at 30th November 2009
COST SAVINGS ACHIEVED - To date TOTAL COST SAVINGS - Full year
Directorate £000 Target Actual Variance%
VarianceOriginal target
Projected Variance%
Variance Woman and Child 217 345 129 59% 304 396 92 30% Surgery 651 304 (347) -53% 976 389 (587) -60% Facilities 245 478 233 95% 351 635 284 81% Finance and Information 87 143 56 64% 115 185 70 61% HR and Communications 14 31 17 126% 18 38 19 106% Nursing and Governance 7 25 17 241% 7 31 24 331% Medical Director 5 9 4 72% 8 13 6 78% Trust Office 30 111 81 274% 34 119 85 246% Overheads 107 107 - 0% 160 160 - 0% Operations 16 19 3 20% 17 22 5 32% Clinical Support 605 846 241 40% 876 1,141 265 30% Medicine 755 1,036 281 37% 1,116 1,547 431 39%
TOTAL 2,738 3,452 714 26% 3,982 4,676 694 17%
SUMMARISED CIP TYPE COST SAVINGS ACHIEVED - To dateTOTAL COST SAVINGS
Projected - Full year (£'000s)Projection Recurrent Non-recurrent Recurrent Non-recurrent
Target Actual Target Actual Target Actual Target Actual PAY 1,103 1,231 631 1,004 1,666 1,834 842 1,240 AGENCY/BANK 109 38 10 10 163 59 15 15 DRUGS 67 80 - - 101 112 - - CLINICAL SUPPLIES 81 35 - - 122 52 - - OTHER NON-PAY 598 783 131 272 896 1,039 166 324 IT COSTS 8 1 - - 12 2 - -
TOTAL 1,966 2,167 772 1,285 2,960 3,097 1,022 1,579
14p14 November 09
The above table shows financial performance by main specialty lines for the period to October 09. This summary now reflects the changes to the income budget made to the September financial reports. In addition, the October financial position now reflects the actual income position for the first quarter SLA contract. The current Obstetric performance reflects over-commissioned activity by NHS Suffolk
The SLR above reflects the published October financial information.
Summary Service Line Report for October 2009
Total Income to cover Specialty
Costs
Total Expenditure after CRES
Surplus / DeficitTotal Income to cover Specialty
Costs
Total Expenditure after CRES
Surplus / DeficitTotal Income to cover Specialty
Costs
Total Expenditure after CRES
Surplus / Deficit
Surgical Directorate Surgical Directorate Surgical Directorate
General Surgery 7,258,203 7,604,850 ( 346,647 ) General Surgery 6,617,587 7,492,705 ( 875,118 ) General Surgery 640,616 112,145 528,471 Urology 2,779,650 2,920,345 ( 140,695 ) Urology 2,420,299 2,810,922 ( 390,623 ) Urology 359,351 109,423 249,929 Trauma & Orthopaedics 10,960,108 9,209,569 1,750,539 Trauma & Orthopaedics 11,086,136 9,010,303 2,075,833 Trauma & Orthopaedics ( 126,028 ) 199,266 ( 325,294 )Ear, Nose & Throat 3,082,795 1,970,314 1,112,481 Ear, Nose & Throat 2,498,066 1,781,038 717,028 Ear, Nose & Throat 584,729 189,276 395,453 Ophthalmology 4,903,915 3,244,350 1,659,565 Ophthalmology 4,074,368 3,154,457 919,910 Ophthalmology 829,548 89,893 739,655 Dental Surgery 706,008 584,910 121,097 Dental Surgery 569,974 564,210 5,764 Dental Surgery 136,034 20,701 115,333 Plastic Surgery 646,463 510,450 136,014 Plastic Surgery 500,844 404,741 96,103 Plastic Surgery 145,620 105,709 39,911 Thoracic Surgery 9,799 7,537 2,262 Thoracic Surgery 9,691 7,707 1,983 Thoracic Surgery 108 ( 171 ) 279
Total Surgical Directorate 30,346,942 26,052,325 4,294,617 Total Surgical Directorate 27,776,964 25,226,084 2,550,880 Total Surgical Directorate 2,569,978 826,241 1,743,737
Medical Directorate Medical Directorate Medical Directorate
General Medicine 9,483,696 8,054,818 1,428,878 General Medicine 9,175,709 7,900,054 1,275,655 General Medicine 307,987 154,764 153,223 Geriatric Medicine 6,490,628 7,692,790 ( 1,202,162 ) Geriatric Medicine 6,887,165 7,649,284 ( 762,119 ) Geriatric Medicine ( 396,537 ) 43,506 ( 440,043 )Cardiology 1,715,260 1,459,499 255,761 Cardiology 863,149 1,424,625 ( 561,476 ) Cardiology 852,111 34,875 817,236 Coronary CU 27,184 523,552 ( 496,368 ) Coronary CU 4,179 505,634 ( 501,455 ) Coronary CU 23,005 17,918 5,087 Thoracic Medicine 987,322 1,399,706 ( 412,384 ) Thoracic Medicine 962,523 1,462,689 ( 500,166 ) Thoracic Medicine 24,800 ( 62,983 ) 87,783 A&E 2,486,505 4,208,514 ( 1,722,009 ) A&E 2,445,734 3,989,969 ( 1,544,235 ) A&E 40,771 218,545 ( 177,774 )Clinical Haematology 1,753,081 1,533,141 219,940 Clinical Haematology 1,391,402 1,524,943 ( 133,541 ) Clinical Haematology 361,680 8,198 353,482 Dermatology 1,121,704 981,729 139,974 Dermatology 1,384,880 948,594 436,286 Dermatology ( 263,177 ) 33,135 ( 296,311 )GU Medicine 521,398 474,943 46,454 GU Medicine 418,226 484,106 ( 65,880 ) GU Medicine 103,172 ( 9,162 ) 112,334 Neurology 410,486 397,703 12,783 Neurology 389,732 407,654 ( 17,922 ) Neurology 20,754 ( 9,951 ) 30,705 Rheum 1,515,094 1,700,695 ( 185,602 ) Rheum 1,672,698 1,665,571 7,127 Rheum ( 157,605 ) 35,124 ( 192,729 )Clinical Oncology 1,951,612 2,165,834 ( 214,222 ) Clinical Oncology 1,659,275 2,160,304 ( 501,029 ) Clinical Oncology 292,337 5,530 286,807 Pain 326,581 319,111 7,470 Pain 367,280 354,247 13,033 Pain ( 40,699 ) ( 35,136 ) ( 5,563 )
Total Medical Directorate 28,790,550 30,912,035 ( 2,121,485 ) Total Medical Directorate 27,621,951 30,477,674 ( 2,855,723 ) Total Medical Directorate 1,168,599 434,361 734,237
Woman & Child Woman & Child Woman & Child
Maternity Services Maternity Services Maternity ServicesObstetrics 2,236,273 1,766,049 470,224 Obstetrics 3,986,987 1,743,568 2,243,419 Obstetrics ( 1,750,714 ) 22,481 ( 1,773,195 )Midwifery 1,644,489 1,947,183 ( 302,694 ) Midwifery 2,273,194 1,969,103 304,092 Midwifery ( 628,705 ) ( 21,920 ) ( 606,785 )Community Midwifery 799,128 1,126,556 ( 327,428 ) Community Midwifery 806,088 1,144,312 ( 338,225 ) Community Midwifery ( 6,959 ) ( 17,756 ) 10,797 Ante Natal 56,224 626,980 ( 570,756 ) Ante Natal 57,151 648,842 ( 591,691 ) Ante Natal ( 927 ) ( 21,862 ) 20,935 Total 4,736,114 5,466,768 ( 730,654 ) Total 7,123,420 5,505,825 1,617,595 Total ( 2,387,306 ) ( 39,058 ) ( 2,348,249 )
Children's Services Children's Services Children's ServicesPaediatrics 2,475,578 1,929,801 545,777 Paediatrics 2,401,937 1,970,170 431,768 Paediatrics 73,641 ( 40,368 ) 114,009 SCBU 1,105,195 1,096,655 8,539 SCBU 1,078,613 1,102,341 ( 23,728 ) SCBU 26,582 ( 5,685 ) 32,267 Total 3,580,773 3,026,457 554,316 Total 3,480,550 3,072,510 408,040 Total 100,223 ( 46,054 ) 146,276
Gynaecology 2,571,933 2,284,085 287,848 Gynaecology 2,342,367 2,220,991 121,376 Gynaecology 229,566 63,094 166,472
Total Woman & Child 10,888,820 10,777,310 111,510 Total Woman & Child 12,946,338 10,799,327 2,147,011 Total Woman & Child ( 2,057,518 ) ( 22,017 ) ( 2,035,501 )
Other Support Services, incl Radiography, Critical Care, Direct Access and Block.
7,819,378 5,303,797 2,515,581 Other Support Services, incl Radiography, Critical Care, Direct Access and Block.
7,682,083 5,384,290 2,297,793 Other Support Services, incl Radiography, Critical Care, Direct Access and Block.
137,295 ( 80,493 ) 217,788
Trust Total 77,845,690 73,045,467 4,800,223 Trust Total 76,027,336 71,887,375 4,139,961 Trust Total 1,818,354 1,158,092 660,262
Specialty Summary Report
Actual
Specialty Summary Report Specialty Summary Report
Budget VariancePeriod to 31st October 2009 Period to 31st October 2009 Period to 31st October 2009
15p15 November 09
£000
's£0
00's
£000
's£0
00's
£000
's£0
00's
FIX
ED
AS
SE
TS:
Tang
ible
Fix
ed A
sset
s76
,032
75,4
4976
,930
CU
RR
EN
T A
SS
ETS
:In
vent
orie
s2,
157
2,31
22,
177
Deb
tors
NH
S D
ebto
rs3,
412
3,16
12,
316
Non
NH
S T
rade
deb
tors
732
740
782
Pro
visi
on fo
r im
pairm
ent o
f deb
tors
(96)
(96)
(96)
Pre
paym
ents
687
561
687
Oth
er d
ebto
rs1,
147
856
1,07
75,
882
5,22
24,
766
Cas
h at
ban
k an
d in
han
d5,
862
10,9
7111
,487
TOTA
L C
UR
RE
NT
AS
SE
TS13
,901
18,5
0518
,430
Non
Cur
rent
Ass
ets
held
for s
ale
1,95
71,
957
1,95
7C
UR
RE
NT
LIA
BIL
ITIE
S:
Cur
rent
Inst
allm
ents
on
loan
s(1
,650
)(1
,325
)(1
,000
)N
HS
Cre
dito
rs(1
,775
)(2
,201
)(1
,859
)N
on N
HS
trad
e cr
edito
rs -
Rev
enue
(1,6
50)
(996
)(9
75)
Non
NH
S tr
ade
cred
itors
- C
apita
l(7
34)
(173
)(1
,999
)Ta
x an
d S
ocia
l sec
urity
(1,9
32)
(1,8
89)
(1,9
90)
Oth
er C
redi
tors
and
Acc
rual
s(4
,267
)(5
,311
)(4
,944
)D
efer
red
Inco
me
(3,5
36)
(3,4
06)
(3,4
93)
Pro
visi
ons
for l
iabi
litie
s an
d ch
arge
s(8
2)(1
01)
(102
)C
UR
RE
NT
LIA
BIL
ITIE
S(1
5,62
6)(1
5,40
2)(1
6,36
2)
NE
T C
UR
RE
NT
AS
SE
TS/(L
IAB
ILIT
IES
)(1
,725
)3,
103
2,06
8
TOTA
L A
SS
ETS
LE
SS
CU
RR
EN
T LI
AB
ILIT
IES
74,3
0780
,509
80,9
55
NO
N C
UR
RE
NT
LIA
BIL
ITIE
SLo
ans
falli
ng d
ue a
fter m
ore
than
one
yea
r(3
,500
)(3
,000
)(2
,500
)P
rovi
sion
for L
iabi
litie
s an
d C
harg
es(3
11)
(298
)(3
02)
TOTA
L A
SS
ETS
EM
PLO
YE
D70
,496
77,2
1178
,153
TAX
PA
YE
RS
EQ
UIT
Y:
Pub
lic d
ivid
end
capi
tal
58,2
5058
,250
58,2
50R
eval
uatio
n re
serv
e15
,874
15,8
7415
,874
Don
ated
ass
et re
serv
e3,
665
3,66
53,
365
Inco
me
and
expe
nditu
re re
serv
e(5
,336
)(5
78)
664
TOTA
L TA
XP
AY
ER
S E
QU
ITY
72,4
5377
,211
78,1
53
KP
IJu
n 20
09Ju
l 200
9A
ug 2
009
Sep
200
9O
ct 2
009
Nov
200
9Tr
ade
debt
or d
ays
- NH
S4.
15.
15.
24.
25.
85.
1Tr
ade
debt
or d
ays
- Non
NH
S41
.146
.654
.741
.841
.531
.2Tr
ade
cred
itor d
ays
0.2
1.3
1.1
1.8
2.2
3.8
Non
NH
S in
voic
es p
aid
with
in 1
0 da
ys (%
)47
.855
.960
.555
.061
.365
.3
Deb
tors
- Th
e m
ain
chan
ge fr
om th
e st
art o
f the
yea
r rel
ates
to th
e le
vel o
f ove
rper
form
ance
invo
ices
incl
uded
with
in N
HS
deb
tors
. Th
ese
have
now
bee
n re
ceiv
ed a
nd re
flect
a m
ore
norm
al le
vel o
f deb
tors
. A
ll ot
her d
ebto
rs re
mai
n co
nsis
tent
with
the
star
t of t
he y
ear.
Incl
uded
w
ithin
deb
tors
ther
e is
a to
tal o
f £52
0k in
rela
tion
to th
e C
olla
bora
tive
Pro
cure
men
t Hub
. D
urin
g N
ovem
ber a
tota
l of £
57k
was
invo
iced
a
tota
l of £
181k
was
col
lect
ed in
the
mon
th.
It sh
ould
als
o be
not
ed th
at ti
ghte
r cre
dit c
ontro
l has
resu
lted
in a
redu
ctio
n in
non
NH
S d
ebto
r da
ys.
Cas
h an
d ba
nk -
The
leve
l of c
ash
rem
ains
hig
h an
d w
ill c
ontin
ue a
t thi
s le
vel.
The
mai
n re
ason
for t
his
is th
e re
ciep
t of
unde
rper
form
ance
invo
ices
and
the
incr
ease
in n
on tr
ade
cred
itors
(prin
cipa
lly c
apita
l - a
s pr
ojec
ts h
ave
a de
laye
d st
art a
nd th
eref
ore
invo
ices
are
like
ly to
be
accr
ued
at th
e ye
ar e
nd).
The
fore
cast
refle
cts
the
curr
ent I
&E
fore
cast
.C
redi
tors
and
loan
s - A
s no
ted
abov
e ca
pita
l cre
dito
rs w
ill b
e hi
gh a
t the
yea
r end
. Th
e le
vel o
f loa
ns w
ill d
ecre
ase
refle
ctin
g th
e ag
reed
re
paym
ent s
ched
ule.
In
line
with
Gov
ernm
ent r
eque
st th
e Tr
ust i
s pa
ying
SM
Es
with
in 1
0 da
ys w
here
pos
sibl
e.
The
targ
et o
f 60%
is n
ow b
eing
ach
ieve
d. T
here
are
a n
umbe
r of r
even
ue c
redi
tors
in re
latio
n to
the
CP
H th
ese
are
rela
tivel
y sm
all.
Th
e re
serv
e in
rela
tion
to th
e C
PH
sur
plus
of i
ncom
e ov
er e
xpen
ditu
re to
talli
ng £
1,23
7K is
hel
d w
ithin
oth
er c
redi
tors
BA
LAN
CE
SH
EE
T A
S A
T 30
NO
VE
MB
ER
200
9
The
bala
nce
shee
t ref
lect
s th
e po
sitio
n of
the
Trus
t as
at 3
0 N
ovem
ber 2
009
and
the
fore
cast
as
at 3
1 M
arch
201
0. T
he fo
rmat
refle
cts
the
mov
e to
IFR
S re
porti
ng.
The
mai
n ar
eas
for c
onsi
dera
tion
are:
-Fi
xed
asse
ts -
The
mov
emen
ts re
flect
the
valu
e of
the
capi
tal p
rogr
amm
e le
ss th
e de
prec
iatio
n ch
arge
. N
o in
dexa
tion
of fi
xed
asse
ts h
as
been
ass
umed
as
ther
e is
insu
ffici
ent g
uida
nce
to d
eter
min
e w
hat t
he li
kely
cha
nge
in v
alue
s w
ill b
e. T
he T
rust
is c
urre
ntly
in th
e pr
oces
s of
reva
luin
g its
land
and
bui
ldin
gs u
sing
the
Dis
trict
Val
uatio
n S
ervi
ce. T
he fi
gure
s ab
ove
have
not
bee
n am
ende
d to
take
acc
ount
of t
he
reva
luat
ion.
The
ass
ets
held
for r
esal
e ha
ve b
een
anal
ysed
sep
arat
ely.
Mar
ch 2
009
Nov
embe
r 20
09Fo
reca
st M
arch
201
0
16p16 November 09
West Suffolk Hospitals - Rolling cash forecast to 31 March 2011
£000QTR to JUNE
2009QTR to SEPT
2009 OCT NOV DECQTR to DEC
2009 JAN FEB MARQTR to MAR
2010FULL YEAR
2009/10
INCOME
BAL B/FWD 5,858 10,417 10,013 11,058 10,963 10,013 11,347 11,576 11,991 11,347 5,858
NHS Clinical Income 34,570 34,278 11,256 11,457 10,942 33,655 10,777 10,777 12,251 33,805 136,308
Other NHS Income 3,403 2,171 1,184 750 685 2,619 700 685 685 2,070 10,263
Loan/PDC advance 0 0 0 0 0 0 0 0 0 0 0
Income Generation 292 294 109 111 93 313 93 93 93 279 1,178
RTA 150 76 17 40 21 78 21 21 21 63 367
Interest 2 9 3 3 3 9 3 3 3 9 29
Misc Other 1,865 1,526 431 443 376 1,250 376 376 376 1,128 5,769
Disposal of Property 0 0 0 0 0 0 0 0 0 0 0
TOTAL INCOME 40,282 38,354 13,000 12,804 12,120 37,924 11,970 11,955 13,429 37,354 153,914
EXPENDITURE
Pay Costs 14,127 14,269 4,739 4,940 4,820 14,499 4,820 4,920 4,810 14,550 57,445
Tax/Pension 9,409 9,469 3,179 3,183 3,115 9,477 3,115 3,115 3,115 9,345 37,700
Creditors 7,714 7,726 2,363 2,491 2,221 7,075 2,221 2,168 2,168 6,557 29,072
Drugs/Stores/NHS Litigation 4,027 4,111 1,411 1,667 1,180 4,258 1,180 937 941 3,058 15,454
PDC Payments 0 1,400 0 0 0 0 0 0 1,372 1,372 2,772
Interest on loans 0 124 0 0 0 0 0 0 102 102 226
Capital expenditure 446 834 263 618 400 1,281 405 400 600 1,405 3,966
Misc 0 0 0 0 0 0 0 0 0 0 0
Repayment of loans 0 825 0 0 0 0 0 0 825 825 1,650
TOTAL EXPENDITURE 35,723 38,758 11,955 12,899 11,736 36,590 11,741 11,540 13,933 37,214 148,285
BALANCE C/fwd 10,417 10,013 11,058 10,963 11,347 11,347 11,576 11,991 11,487 11,487 11,487
FORECAST
The cash flow forecast reflects the actual cash position as at 30 November 2009. The model takes account of the Department of Health loan including its repayment schedule and interest charges. The Trust is required to report against EFL however relaxation of rules allow for Trust's hold cash balances above it's EFL target. The figure for April includes the receipt of overperfomance on contracts up to the end of the financial year. The lower cash balance in September is a result of the repayment of loans and associated interest and the half yearly payment of Public Capital Dividend. The forecast at the year end reflects the current view on the surplus for the year.
ACTUAL
17p17 November 09
Wes
t Suf
folk
Hos
pita
l NH
S Tr
ust C
apita
l Pro
gram
me
200
9-20
10R
evis
edTo
tal
Tota
lSc
hem
eB
udge
tEx
pend
iture
Fore
cast
2009
-10
as a
t 30
Nov
09
Expe
nditu
re
Pre-
Com
mitm
ents
(inc
08/
09 C
ontr
actu
al C
omm
itmen
ts)
Phar
mac
y U
nit/R
obot
ic
1,42
7,00
056
0,27
41,
427,
274
Educ
atio
n C
entre
- Le
ctur
e Th
eatre
494,
000
50,6
3249
3,63
2O
ther
cos
ts72
3,00
053
1,79
977
3,98
4To
tal
2,64
4,00
01,
142,
706
2,69
4,89
1
Site
Ser
vice
s/B
ackl
og M
aint
enan
ceTo
tal
1,01
3,83
513
,433
227,
851
Clin
ical
Equ
ipm
ent R
epla
cem
ent
Tota
l49
3,14
939
3,83
446
2,25
4
Non
Clin
ical
Equ
ipm
ent
Tota
l12
3,07
574
,802
128,
897
IM &
TEl
ectro
nic
Ros
terin
g (c
/fwd
08/0
9)12
8,00
010
2,01
112
8,15
3N
HS
Num
ber I
nter
faci
ng16
4,00
052
,881
169,
960
Addi
tiona
l EPR
O F
unct
iona
lity50
,000
23,8
7250
,015
Con
tract
Man
agem
ent S
yste
m (S
ollis
) Dev
elop
men
t12
9,00
023
,000
129,
000
Dat
a W
areh
ouse
Sof
twar
e D
evel
opm
ent
145,
000
39,6
1713
5,34
2O
rder
s &
Res
ults
Pat
holo
gy D
evel
opm
ent
100,
000
23,6
2798
,020
Oth
er33
0,87
588
,770
288,
214
Tota
l1,
046,
875
353,
779
998,
704
Dev
elop
men
t Sch
emes
Sing
le S
ex A
ccom
mod
atio
n43
2,00
031
9,64
638
6,64
6M
idwi
fery
Led
Birt
hing
Uni
t36
0,00
016
852
,516
Oth
er24
4,26
41,
413
237,
413
Tota
l1,
036,
264
321,
226
676,
574
Tota
l all
Cap
ital p
roje
cts
6,35
7,19
82,
299,
780
5,18
9,17
2
Asse
t Dis
posa
l (la
nd s
ales
) Pha
se 2
Har
ps C
lose
25,0
003,
284
5,28
4
Tota
l Com
mitm
ent
6,38
2,19
82,
303,
064
5,19
4,45
6
Cap
ital F
undi
ng4,
237,
000
Addi
tiona
l Ext
erna
l Fun
ding
1,04
5,00
0C
apita
l Exp
endi
ture
Lim
it5,
282,
000
5,28
2,00
05,
282,
000
Und
er/(O
ver)
Com
mitt
ed-1
,100
,198
87,5
44
The
2009
/10
capi
tal p
lan
was
agre
ed a
t £6,
382k
reco
gnis
ing
fund
ing
of £
5,28
2k w
as a
vaila
ble.
Cap
ital e
xpen
ditu
re is
bei
ng
man
aged
to m
atch
fund
ing
thro
ugh
proj
ect f
orec
astin
g an
d pr
ojec
t tim
ing.
Proj
ect s
pend
to d
ate
(as
at 3
0 N
ovem
ber 2
009)
is £
2,30
3k re
pres
entin
g 44
% o
f the
cap
ital p
lan.
IM&T
pro
ject
s ar
e fo
reca
stin
g an
ove
rall u
nder
spen
d of
£42
k, F
acilit
ies
proj
ects
an
unde
rspe
nd o
f £1,
102k
, and
unu
sed
cont
inge
ncy
is lik
ely
to b
e c.
£40
k. M
ost o
f the
se u
nder
spen
ds re
flect
tim
ing
of c
omm
itmen
ts a
nd d
o no
t affe
ct th
e ov
eral
l long
-te
rm c
apita
l pla
ns.
The
unde
rspe
nds
note
d ab
ove
have
the
effe
ct o
f for
ecas
ting
an o
vera
ll und
ersp
end
of £
88k